Financials
- Market Capitalization 392.49 M
- Employee 350
- Founded 2012
- CEO David Moatazedi
- Website www.evolus.com
- Headquarter Delaware, United States
- FIGI BBG005CX4HK8
- Industry 药品制造—专业与仿制药
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-6.23
市销率
0.88
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3085 | CGC Canopy Growth Corporation - Common Shares | 0.96 USD | 0.00% | -1.03% | -3.03% | -13.51% | 405.27 M USD | ||
| 3089 | EBS Emergent BioSolutions Inc. Common Stock | 7.89 USD | +5.06% | -3.66% | -4.94% | -26.40% | 407.09 M USD | ||
| 3156 | AKBA Akebia Therapeutics, Inc. - Common Stock | 1.39 USD | -0.71% | -2.11% | +51.09% | +17.80% | 372.88 M USD | ||
| 3275 | ORGO Organogenesis Holdings Inc. - Class A | 2.49 USD | +6.41% | +0.81% | +2.89% | -41.96% | 320.40 M USD |